patients with tissue loss showed a trend toward an increase in amputation in the group with ENDO in the SFA/POP region and a statistically significant increase in amputation when ENDO was performed for infrapopliteal disease (7.2% vs 4.9%; P ¼ .017). Multivariable analysis revealed that although bypasses have a higher risk for cardiac, pulmonary, and wound complications, they resulted in a significantly lower rate of amputations compared with endovascular interventions in patients with tissue loss and infrapopliteal disease (Table) .
Conclusions: Surgical bypasses provided significantly better limb salvage than endovascular intervention in patients with infrapopliteal disease and tissue loss. Surgical bypasses should be preferred in those patients unless they present with prohibitive cardiopulmonary or wound risk.
Author Disclosures: R. Amdur: Nothing to disclose; K. B. Lee: Nothing to disclose; J. Lu: Nothing to disclose; R. Macsata: Nothing to disclose; B. Nguyen: Nothing to disclose; J. J. Ricotta: Nothing to disclose; R. Sebastian: Nothing to disclose; A. N. Sidawy: Nothing to disclose.
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Does Preoperative Anemia Affect Outcomes After Lower Extremity Open Bypass?
Ziad Al Adas, Mitchell R. Weaver, Timothy Nypaver, Alexander Shepard, Dragos Galusca, Loay Kabbani. Henry Ford Hospital, Detroit, Mich
Objective: Preoperative anemia has been shown in several surgical disciplines to increase adverse events, overall hospital costs, and 30-day mortality. The association between postoperative complications and preoperative anemia has not been fully established in vascular surgery. By using the Michigan State Vascular Quality Initiative (VQI) data for patients who underwent open bypasses for peripheral arterial disease, we sought to determine whether preoperative anemia is a risk factor for postoperative complications in patients undergoing open bypasses for peripheral arterial disease.
Methods: A retrospective analysis of a prospectively collected database was performed using VQI data from the Michigan region for all open suprainguinal and infrainguinal bypasses performed between April 2011 and March 2017. Anemia was defined by the World Health Organization definition, hemoglobin concentration <13 g/dL for men and <12 g/dL for women, and classified into three groups based on its severity: mild, 10 to 13 g/dL for men and 10 to 12 g/dL for women; moderate, 8 to 10 g/dL; and severe, <8 g/dL. Association between preoperative anemia and postoperative complications was analyzed using univariate and then multivariate analysis, specifically looking at cardiac complications (composite of myocardial infarction, dysrhythmia, and congestive heart failure), acute kidney injury (AKI), and 30-day mortality.
Results: During the study period, 1755 bypass procedures, 1288 infrainguinal and 467 suprainguinal, were recorded in the regional VQI registry. Average age was 65 years, and men composed 68% of the cohort. Seventy-nine percent were white. Forty-seven percent (827) were anemic: 70% (n ¼ 584) with mild anemia, 26% (n ¼ 213) with moderate anemia, and 4% (n ¼ 30) with severe anemia. After adjustment for other variables using multivariate regression, mild and moderate preoperative anemia was not associated with cardiac complications, AKI, or 30-day mortality. The incidence of severe preoperative anemia was very low, and the study was not powered enough to detect any association with outcomes for the severe anemia group. However, postoperative blood transfusion was associated with cardiac complications, AKI, and 30-day mortality.
Conclusions: Preoperative anemia, at least in its mild and moderate forms, was not associated with postoperative complications or mortality after open bypass for arterial occlusive disease.
Author Disclosures: Z. Al Adas: Nothing to disclose; D. Galusca: Nothing to disclose; L. Kabbani: Nothing to disclose; T. Nypaver: Nothing to disclose; A. Shepard: Nothing to disclose; M. R. Weaver: Nothing to disclose. Objective: Critical limb ischemia (CLI) patients with long femoralpopliteal chronic total occlusions (CTOs) and limited bypass options face significant amputation risk. Retrograde pedal access (RPA) has been previously described as a technique for endovascular treatment of tibial disease. We describe our experience with recanalization of long-segment femoral-popliteal occlusions through RPA in high-risk CLI patients.
IP211.
Recanalization of Long Chronic Total Occlusions
Methods: All patients undergoing attempted RPA for lower extremity revascularization during 2 years at our institution were analyzed. A subset of patients with CLI and TransAtlantic Inter-Society Consensus (TASC) C or D femoral-popliteal CTOs who were not bypass candidates (because of failed prior revascularizations, excessive comorbidities, or no autologous conduit) were analyzed for this study. Demographic, hemodynamic, and procedural data were collected. Outcomes were major adverse events (death, myocardial infarction, acute renal failure, major pulmonary events, wound complications, and access vessel thrombosis), length of stay, limb salvage, and patency.
Results: Follow-up was 286 days (range, 4-593 days). Eighteen patients with CLI underwent recanalization of a TASC C or D femoral-popliteal CTO. These were relatively young (mean age, 64 years), with significant comorbidities: 39% prior coronary artery bypass graft or percutaneous coronary intervention, 35% chronic renal insufficiency, 62% diabetic, and 39% prior failed lower extremity bypass or peripheral vascular intervention. Ninety-four percent of these procedures were performed under general anesthesia. In 50% of cases, pedal access was achieved percutaneously under ultrasound guidance. Fifty-six percent of patients had a concomitant femoral endarterectomy. All CTO patients were treated with stents or stent grafts after femoral-popliteal atherectomy (17%) or subintimal percutaneous transluminal angioplasty (83%). The median treatment length was 350 mm. Median procedure time was 227 minutes. There were eight endovascular reinterventions during follow-up at a mean of 125 days. Key procedural and 270-day event rates are summarized in the Table. Conclusions: RPA offers a viable technical alternative for treatment of TASC C and femoral-popliteal CTOs in high-risk CLI patients. Relatively high rates of technical success with significant hemodynamic improvement can be achieved with a low major adverse event rate, short hospital length of stay, and good short-term limb salvage. Reinterventions are common, highlighting the need for close surveillance and further assessment of long-term durability.
Author Disclosures: S. J. Carlson: Nothing to disclose; P. P. Goodney: Nothing to disclose; B. Nolan: Nothing to disclose; R. J. Powell: Nothing to disclose; E. L. Spangler: Nothing to disclose; J. Stableford: Nothing to disclose; D. H. Stone: Nothing to disclose; B. D. Suckow: Nothing to disclose. e142 Abstracts
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